| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in Single-Patient Trials for Drug Treatment Optimization and Risk Management
|
Reitberg, Donald P.
|
|
|
39 |
2 |
p. 119-124
|
artikel
|
| 2 |
A New Clinical Trial Design Combining Phases 2 and 3: Sequential Designs with Treatment Selection and a Change of Endpoint
|
Todd, Susan
|
|
|
39 |
2 |
p. 109-118
|
artikel
|
| 3 |
Choosing the Number of Doses and the Cohort Size for Phase 1 Dose-Escalation Studies
|
Zhou, Yinghui
|
|
|
39 |
2 |
p. 125-137
|
artikel
|
| 4 |
Clinical Trial Capacity in East Africa: A Pilot Survey
|
Kimanani, Ebi
|
|
|
39 |
2 |
p. 177-184
|
artikel
|
| 5 |
Drug Information Obscured on Over-the-Counter Medication Labels by External Tags
|
Sansgiry, Sujit S.
|
|
|
39 |
2 |
p. 159-170
|
artikel
|
| 6 |
Good Review Practices: The First Step Forward for the Korea Food and Drug Administration
|
Lee, Howard
|
|
|
39 |
2 |
p. 185-192
|
artikel
|
| 7 |
Model-Based Correction to the QT Interval for Heart Rate for Assessing Mean QT Interval Change Due to Drug Effect
|
Wei, Greg C. G.
|
|
|
39 |
2 |
p. 139-148
|
artikel
|
| 8 |
Recent Developments in European Pharmaceutical Law 2004: A Legal Point of View
|
Hartmann, Markus
|
|
|
39 |
2 |
p. 193-207
|
artikel
|
| 9 |
The Application of Metrics to Determine the Work Rate for Producing the First Draft of the Clinical Study Report: A Case Study
|
Purcell, Thomas J.
|
|
|
39 |
2 |
p. 171-175
|
artikel
|
| 10 |
The Expected Toxicity Rate at the Maximum Tolerated Dose in Bridging Studies in Alzheimer’s Disease
|
Kang, Seung-Ho
|
|
|
39 |
2 |
p. 149-157
|
artikel
|
| 11 |
6th Middle East Regulatory Conference (MERC): Key Proceedings
|
Hewitt, Brian
|
|
|
39 |
2 |
p. 209-214
|
artikel
|
Tijdschrift beschrijving